CRESENCE AS

Closed at April 13th, 2023

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Operation time: 2 years; - Jan 25, 2021 to Apr 13, 2023
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 40,000; 1 share class
Total number of shareholders: 4; 1 company, 3 persons

Financials

Total equity 2021: 41,632; NOK

Last update: Apr 13, 2023

Management

No available data

Ownership

Company shareholders

Name	Share class	Number of shares	Share
F FUGELLI INVEST AS	Ordinary shares	10,000	25 %
BA B Lang Alois	Ordinary shares	10,000	25 %
FY Francois Yves Curtin 1964	Ordinary shares	10,000	25 %
NF Nicoletti Ferdinando	Ordinary shares	10,000	25 %

Last update: Apr 4, 2024

Financials

in NOK

Summary

Year	2021
Total operating income	0
Annual Total Result	0
Total assets	41,632
Total liabilities	0
Total equity	41,632

P&L

Year	2021
Total operating income	0
Total operating costs	0
Operating result	0
Financial income/costs	0
Profit before tax	0
Total tax & extraordinary income/cost	0
Annual Total Result	0

Balance overview

Year	2021
Total fixed assets	0
Total current assets	41,632
Total assets	41,632
Short term debt	0
Long term debt	0
Total liabilities	0
Contributed capital	41,632
Retained earnings	0
Total equity	41,632
Total equity and liabilities	41,632

CRESENCE AS926 188 100

CRESENCE AS

Keywords

Organization

Ownership

Financials

Management

Ownership

Company shareholders

Financials

Summary

P&L

Balance overview

Classification